The optimal dose of triptorelin for triggering final oocyte maturation in patients at high-risk for OHSS: a randomized clinical trial

被引：0
|
作者：
Lainas, G. T. [1 ]
Bosdou, J. K. [1 ]
Venetis, C. A. [2 ]
Sfontouris, I. A. [3 ]
Chatzimeletiou, K. [1 ]
Zepiridis, L. [1 ]
Makedos, A. [1 ]
Daniilidis, A. [1 ]
Mitsoli, A. [1 ]
Savvaidou, D. [1 ]
Lainas, T. G. [3 ]
Tarlatzis, B. C. [1 ]
Kolibianakis, E. M. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Sch Med, Unit Human Reprod, Dept Obstet & Gynecol 1, GR-54006 Thessaloniki, Greece
[2] Univ New S Wales, Sch Womens & Childrens Hlth UNSW Med, Sydney, NSW, Australia
[3] EUGONIA, Eugonia Unit Assisted Reprod, Athens, Greece
来源：
HUMAN REPRODUCTION | 2015年 / 30卷
关键词：
agonist trigger; triptorelin dose; high risk for OHSS; oocyte maturity; OHSS prevention;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-219
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [21] The use of gonadotropin releasing hormone (GnRH) agonist to induce oocyte maturation in high-risk patients undergoing IVF reduces the risk of ovarian hyperstimulation syndrome (OHSS) - A prospective randomized controlled study.
    Engmann, L.
    Diluigi, A.
    Schmidt, D.
    Nulsen, J.
    Maier, D.
    Benadiva, C.
    FERTILITY AND STERILITY, 2006, 86 : S118 - S118
  • [22] DOES EXTENDING THE TIME INTERVAL BETWEEN TRIGGERING FINAL OOCYTE MATURATION AND OOCYTE RETRIEVAL FROM 36 TO 38 HOURS AFFECT IVF OUTCOME? A RANDOMIZED CONTROLLED TRIAL
    Triantafyllidis, S. L.
    Kolibianakis, E. M.
    Venetis, C. A.
    Masouridou, S.
    Zepiridis, L.
    Tarlatzis, B. C.
    FERTILITY AND STERILITY, 2011, 96 (03) : S82 - S82
  • [23] Recruiting high-risk older participants for a randomized clinical trial
    Boult, C
    Boult, L
    Morishita, L
    Pirie, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : P149 - P149
  • [24] A RANDOMIZED TRIAL OF WEEKLY CARDIOTOCOGRAPHY IN HIGH-RISK OBSTETRIC PATIENTS
    LUMLEY, J
    LESTER, A
    ANDERSON, I
    RENOU, P
    WOOD, C
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1983, 90 (11): : 1018 - 1026
  • [25] A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG
    Lainas, G. T.
    Lainas, T. G.
    Sfontouris, I. A.
    Venetis, C. A.
    Kyprianou, M. A.
    Petsas, G. K.
    Tarlatzis, B. C.
    Kolibianakis, E. M.
    HUMAN REPRODUCTION OPEN, 2020, 2020 (03)
  • [26] Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study
    Zhai, Li-Ying
    Zhang, Xiao-Rong
    Liu, Huan
    Ma, Yue
    Xu, Hong-Chang
    EYE, 2020, 34 (09) : 1600 - 1607
  • [27] Effect of a Postdischarge Virtual Ward on Readmission or Death for High-Risk Patients A Randomized Clinical Trial
    Dhalla, Irfan A.
    O'Brien, Tara
    Morra, Dante
    Thorpe, Kevin E.
    Wong, Brian M.
    Mehta, Rajin
    Frost, David W.
    Abrams, Howard
    Ko, Francoise
    Van Rooyen, Patrick
    Bell, Chaim M.
    Gruneir, Andrea
    Lewis, Geraint H.
    Daub, Stacey
    Anderson, Geoff M.
    Hawker, Gillian A.
    Rochon, Paula A.
    Laupacis, Andreas
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (13): : 1305 - 1312
  • [28] Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study
    Li-Ying Zhai
    Xiao-Rong Zhang
    Huan Liu
    Yue Ma
    Hong-Chang Xu
    Eye, 2020, 34 : 1600 - 1607
  • [29] INOVASIA Study: A Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High-Risk Patients
    Akbar, Muhammad Ilham Aldika
    Azis, Muhammad Alamsyah
    Riu, Deviana Soraya
    Wawengkang, Ellen
    Ernawati, Ernawati
    Bachnas, Muhammad Adrianes
    Sulistyowati, Sri
    Dachlan, Erry Gumilar
    Mose, Johanes Cornelius
    Dekker, Gus
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (09) : 1203 - 1211
  • [30] Will the hCG trigger dose used for final oocyte maturation in IVF impact endogenous progesterone during the luteal phase? - A randomized controlled trial
    Svenstrup, L.
    Fedder, J.
    Moller, S.
    Pedersen, D.
    Erb, K.
    Andersen, C. Yding
    Humaidan, P.
    HUMAN REPRODUCTION, 2021, 36 : 25 - 26
12345